000			01531cam a2200325 a 4500
001			2008040293
003			DLC
005			20100524094837.0
008			080915s2008 enka b 001 0 eng
010			_a 2008040293
020			_a9780470511787
020			_a0470511788
040			_aDLC _cDLC _dBTCTA _dBAKER _dYDXCP _dBWKUK _dBWK _dBWX _dCDX _dIAY _dDLC
050	0	4	_aHD9999.B442 _bK44 2008
082	0	0	_a332.63/221 _222
100	1		_aKeegan, Karl D.
245	1	0	_aBiotechnology valuation : _ban introductory guide / _cKarl D. Keegan.
260			_aChichester, England ; _aHoboken, NJ : _bJohn Wiley & Sons, _cc2008.
300			_aix, 206 p. : _bill. ; _c26 cm.
490	1		_aWiley finance
504			_aIncludes bibliographical references (p. [189]-192) and index.
505	0		_aIntroduction -- Traditional valuation methods -- The drug development process -- Biotechnology company valuation -- Decision trees and real options -- Biotechnology investing -- Early stage valuation.
650		0	_aBiotechnology industries _xValuation.
650		0	_aPharmaceutical industry _xValuation.
650		0	_aInvestment analysis.
830		0	_aWiley finance series.
856	4	2	_3Publisher description _uhttp://www.loc.gov/catdir/enhancements/fy0901/2008040293-d.html
856	4	1	_3Table of contents only _uhttp://www.loc.gov/catdir/enhancements/fy0902/2008040293-t.html
952			_w2010-07-16 _p2000000653 _v40.95 _r2012-02-01 _40 _eCoutts _00 _bSKOLKOVO _10 _oHD9999.B442 K44 _d2010-07-16 _t1 _70 _cSHE _g40.95 _yBK _aSKOLKOVO
999			_c135 _d135